Clinical Trial Update: Secondary Prevention of Venous Thrombo Embolism (VTE). [Phase 3]

View source ↗

Summary

Phase 3 trial update for secondary prevention of venous thromboembolism sponsored by Boehringer Ingelheim; the study has completed and results were posted in 20…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Venous Thromboembolism

Snippet

Sponsor: Boehringer Ingelheim | Conditions: Thromboembolism | Phase 3 | Status: COMPLETED | Results posted: 2011-09-14